Viking Therapeutics, Inc. (VKTX) Technical Analysis & Indicators

Viking Therapeutics, Inc. (VKTX) — Price $26.09 (closing price, November 3, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Viking Therapeutics, Inc. (VKTX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß).

Price Performance

1 month-8.37%
3 months-19.43%
Year-to-date-23.74%
1 year-22.52%
3 years+154.31%
5 years+310.87%
10 years+2637.76%

52-Week Range

52-week High$43.15
52-week Low$23.82
Avg Volume (90d)4.1M

Technical Indicators

SMA 50$30.37
SMA 200$32.38
Beta0.82
30-day Volatility (annualised)114.5%
Price vs SMA 50-11.7%
Price vs SMA 200-17.1%

Monthly Close (12 months)

MonthCloseChange
2025-12$35.18
2026-01$29.04-17.5%
2026-02$33.84+16.5%
2026-03$32.54-3.8%
2026-04$31.18-4.2%
2026-05$32.74+5.0%
2026-06$39.01+19.2%
2026-07$31.74-18.6%
2026-08$32.78+3.3%
2026-09$32.60-0.5%
2026-10$27.28-16.3%
2026-11$26.83-1.6%

Upcoming Earnings

DateEPS Est.Revenue Est.
2027-02-10$-1.38
2026-10-28$-1.06
2026-07-29$-1.23
2026-04-29$-1.01
2026-02-11$-0.89$2M
2025-10-22$-0.70
2025-07-23$-0.44

Price

Price$26.09 (closing price, November 3, 2026)
Market Cap$3.3B
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book5.23
Dividend Yield0.00%

Financial Health

Debt / Equity0.43
Current Ratio7.27
Piotroski F-Score1
Altman Z-Score28.62

Related companies: MDGL · NAMS · MBX · SEPN

Explore sector: Healthcare · Biotechnology

More sections of VKTX: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks